Daily Newsletter

20 October 2023

Daily Newsletter

20 October 2023

Midi Health and Memorial Hermann to offer midlife care for women

Midi's virtual clinic offers telehealth services while maintaining a connection with Memorial Hermann-affiliated physicians.

October 19 2023

US-based virtual care clinic Midi Health and not-for-profit health system Memorial Hermann have partnered to provide expert care for women going through midlife hormonal changes.

The partnership aims to address 'life-altering' symptoms that can affect women during the perimenopause and menopause stages.

Midi's virtual clinic offers telehealth services while maintaining a connection with Memorial Hermann-affiliated physicians.

Memorial Hermann women's and children's service line vice-president Dr Victoria Regan said: “With today marking World Menopause Day, it was the perfect occasion to unveil this collaboration as an innovative way to provide our patients experiencing midlife hormonal conditions with specialised care developed by experts in perimenopause and menopause.

“With Midi Health, women now have an integrated solution to meet their full health care needs, in collaboration with their affiliated providers here at Memorial Hermann.”

Patients can access Midi's care directly or through referrals from their Memorial Hermann doctors, receiving personalised care plans developed by perimenopause and menopause experts.

After virtual visits, women may be referred for in-person care such as screenings and surgeries, which will all be covered by insurance in Texas.

Led by experts in women's midlife health, Midi Health aims to fill a healthcare gap for women going through midlife hormonal transitions.

It provides personalised care plans that can include medications, lifestyle coaching and preventative health guidance.

Midi Health CEO and co-founder Joanna Strober said: “We are excited to collaborate with Memorial Hermann to close the gap in care for the millions of women who experience symptoms of menopause.

“Menopause symptoms are correlated with cardiovascular disease, among other challenges which is actually the theme of this year's World Menopause Day.

“By intervening early, women can mitigate their risks. Plus, many women aren't getting the regular screenings they need like mammograms and colonoscopies.

“This programme gives women access to the treatment they need at a crucial stage in their lives.”

AI will become a key driver of medical device innovation

With only a few approved drugs currently available to treat DN by means other than regulation of blood pressure, innovator products that can treat by targeting other factors such as treatment of dyslipidemia, hypertension, or angiotensin inhibition, among others, is a key area of R&D in the DN space and is likely to pave the way for novel therapies in the near future. However, the treatment landscape is expected to remain unchanged due to limited availability of products in the late-stage pipeline currently.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close